↓ Skip to main content

Dove Medical Press

Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic

Overview of attention for article published in Risk Management and Healthcare Policy, May 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
105 Mendeley
Title
Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic
Published in
Risk Management and Healthcare Policy, May 2016
DOI 10.2147/rmhp.s83907
Pubmed ID
Authors

Morenike O Folayan, Bridget G Haire, Brandon Brown

Abstract

The devastation caused by the Ebola virus disease (EVD) outbreak in West Africa has brought to the fore a number of important ethical debates about how best to respond to a health crisis. These debates include issues related to prevention and containment, management of the health care workforce, clinical care, and research design, all of which are situated within the overarching moral problem of severe transnational disadvantage, which has very real and specific impacts upon the ability of citizens of EVD-affected countries to respond to a disease outbreak. Ethical issues related to prevention and containment include the appropriateness and scope of quarantine and isolation within and outside affected countries. The possibility of infection in health care workers impelled consideration of whether there is an obligation to provide health services where personal protection equipment is inadequate, alongside the issue of whether the health care workforce should have special access to experimental treatment and care interventions under development. In clinical care, ethical issues include the standards of care owed to people who comply with quarantine and isolation restrictions. Ethical issues in research include appropriate study design related to experimental vaccines and treatment interventions, and the sharing of data and biospecimens between research groups. The compassionate use of experimental drugs intersects both with research ethics and clinical care. The role of developed countries also came under scrutiny, and we concluded that developed countries have an obligation to contribute to the containment of EVD infection by contributing to the strengthening of local health care systems and infrastructure in an effort to provide fair benefits to communities engaged in research, ensuring that affected countries have ready and affordable access to any therapeutic or preventative interventions developed, and supporting affected countries on their way to recovery from the impact of EVD on their social and economic lives.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 105 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 19%
Researcher 16 15%
Student > Bachelor 11 10%
Student > Ph. D. Student 8 8%
Other 5 5%
Other 19 18%
Unknown 26 25%
Readers by discipline Count As %
Medicine and Dentistry 22 21%
Nursing and Health Professions 16 15%
Agricultural and Biological Sciences 6 6%
Biochemistry, Genetics and Molecular Biology 5 5%
Social Sciences 4 4%
Other 19 18%
Unknown 33 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2016.
All research outputs
#15,372,369
of 22,869,263 outputs
Outputs from Risk Management and Healthcare Policy
#328
of 616 outputs
Outputs of similar age
#178,984
of 298,384 outputs
Outputs of similar age from Risk Management and Healthcare Policy
#8
of 9 outputs
Altmetric has tracked 22,869,263 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 616 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,384 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.